Vecuronium (initial dose 0.1 mgkg" 1 ; incremental doses 0.04 mg kg" 1 ) was given to 21 normal and 21 anephric patients. There were no gross difference* betwen the two groups in the effect or in the duration of action of either initial or incremental doses, except in two anephric patients who were resistant to the agent. Reversal with neostigmine was satisfactory. In normal patients the initial dose of vecuronium was slower in onset of action than was atracurium 0.5 mgkg' 1 (26 patients): the first two incremental doses of vecuronium were administered significantly earlier than the corresponding increments of atracurium (0.2 mgkg" 1 ), but the duration of action of increments over-all was not greatly different. However, in anephric patients, except in the resistant patients, the behaviour of vecuronium was similar to that of atracurium (26 patients). A comparison with an initial dose of rubocurarine 0.5mgkg" 1 given to 20 anephric patients and tubocurarine 0.6mgkg" 1 given to 21 normal and 20 anephric patients showed tubocurarine to be longer acting and considerably less predictable. This was particularly so in the anephric group, in which its action sometimes persisted after neostigmine had been given.
investigate the use of vecuronium in a group of patients with no renal function, studying a group of normal general surgical and gynaecological patients for comparison. As the techniques of anaesthesia and of investigation were identical to those used in previous studies of atracurium in normal and anephric patients (Hunter, Jones and Utting, 1982a, b) an opportunity was available to compare directly the two new neuromuscular blockers.
It is presumably the absence of the renal route for drug excretion which is responsible for the difficulties encountered when the older non-depolarizing agents are used in anephric patients and the pharmacokinetic consequences of this absence of urinary excretion have been summarized (Buzello and Agoston, 1978) . On the other hand, there are few clinical studies with direct monitoring of neuromuscular function in this field and, for this reason, two groups of anephric patients given tubocurarine 0.5 mg kg" 1 and 0.6mgkg" 1 were investigated also, together with a group of normal patients given tubocurarine 0.6 mg kg" 1 to serve as a basis for comparison.
PATIENTS AND METHODS

Patients
New data from five groups of patients are presented: a group of patients with normal renal function ("normal" patients) who received vecuronium and a group of patients with little or no renal function ("anephric" patients) given the same drug; a group of anephric patients who received tubocurarine in an initial dose of 0.5mgkg"' (no normal patients given tubocurarine in this dose were studied); and a group of normal and a group of anephric patients given tubocurarine in an initial dose of 0.6mgkg~1. Details of the numbers, sex distribution, ages and weights of these patients are given in table I which also gives the comparable data from work on atracurium, most of which have been published previously (Hunter, Jones and Utting, 1982a, b); this comparison is extended to the other tables where relevant. The 67 patients designated normal were all ASA grades 1 and 2. They were presented for a wide variety of general surgical and gynaecological procedures such as vagotomy and pyloroplasty, cholecystectomy, mastectomy, hernia repair and hysterectomy.
None of the 87 patients designated anephric had"a creatinine clearance greater than 2 ml min" 1 and few were secreting any urine at all. Most were being treated with regular haemodialysis (although some had become anuric acutely because of, for example, graft rejection). The majority were receiving one or more anti-hypertensive agents (for example labetalol and hydrallazine) in addition to receiving preparations of iron, vitamins and antacids.
Plasma electrolyte concentrations in the anephric patients were usually within, or almost within, physiological limits except for a mild degree of metabolic acidosis, usual in this type of patient (mean base excess -5.4 mmol litre" 1 ). Plasma creatinine concentrations were between 139 and 1501 mmol litre" 1 (mean 930 mmol litre" 1 ) and urea concentrations between 6 and 51 mmol litre" 1 (mean 22 mmol litre" 1 ). Haemoglobin concentrations were in the range 4.0-15.8 g dl" 1 (mean 7.9 gdl" 1 ). There was no significant difference between the four groups of anephric patients in these respects. Most of the anephric patients were in as good a general condition as might be expected (ASA grade 3). However, 27 out of a total of 87 (31%) were regarded as being in a somewhat worse condition (ASA grade 4). Of these, seven received atracurium, nine received vecuronium, four received tubocurarine in the smaller dose and seven received tubocurarine in the larger dose.
Surgery was performed on the anephric patients for a variety of reasons. Renal transplantation was the commonest operation (29%), followed by exploration of graft and graft nephrectomy (25%), intraperitoneal abdominal surgery (24%) (laparotomy, vagotomy and drainage etc.) and the establishment or revision of an arterio-venous fistula (17%). The distribution of the operations amongst the three groups of anephric patients studied was broadly similar; for example, vecuronium was administered to seven patients for renal transplantation and four for graft nephrectomy; the lower dose of tubocurarine to five transplant patients and five patients for graft nephrectomy; and the higher dose of tubocurarine to six transplant patients and five patients for graft nephrectomy, the corresponding figures for patients receiving atracurium being seven and eight, respectively.
All the patients were interviewed the day after surgery and questioned about their subjective responses. Specifically, they were asked if they had experienced (or were experiencing) blurring of vision or diplopia.
Approval of the trial was obtained from the hospital ethics committee. 
Anaesthesia
The technique of anaesthesia has been described in detail previously (Hunter, Jones and Utting, 1982a) .
Premedication was with diazepam and induction of anaesthesia with fentanyl, droperidol and thiopentone. Anaesthesia was maintained with nitrous oxide in oxygen, sometimes with increments of fentanyl or thiopentone, while the equipment for monitoring neuromuscular function was set up. Once this had been undertaken, the initial dose of neuromuscular blocking drug was given into a fastrunning i.v. infusion and artifkal ventilation established. Tracheal intubation was attempted, the laryngoscope being inserted exactly 90s after neuromuscular blocking drug had been given. No topical analgesia was applied to the larynx. Conditions for tracheal intubation were described as "good" if the vocal cords were abducted and there was no response, such as cough, to the passage of the tracheal tube; "adequate" if there was a slight cough only; and "poor" if there was considerable coughing, other movement or if intubation proved impossible.
Controlled ventilation was continued with 70% nitrous oxide in oxygen without the addition of a volatile adjuvant. Arterial carbon dioxide tension was maintained around 5.3 kPa. To facilitate this an infra-red carbon dioxide analyser (Datex "Normocap"), calibrated with a mass spectrometer, was used continuously and samples of arterial blood were taken from time to time to verify the carbon dioxide tension (Instrumentation Laboratories, ILAB67C).
Increments of fentanyl 25jig were given if heart rate or arterial pressure increased during surgery. Increments of neuromuscular blocker were given when there was a return of the initial twitch of the train-of-four (A 1 ) to about 20% of the control height (A).
The doses of neuromuscular blocking drug, initial and incremental, are shown in table II. (In the case of the two dose schedules of tubocurarine, the initial dose produced less depression of the twitch height than did the other two drugs; this made adequate comparison impossible and results from incremental doses of tubocurarine are not given.)
At the end of surgery atropine 0.6mg was administered, followed, 1 min later, by neostigmine 2.5mg. If, 4min after the neostigmine had been given, the ratio of the first twitch of the train-of-f our to the control (A'/A) was less than 75%, a further dose of atropine 0.6 mg was given followed, 1 min later, by neostigmine 2.5 mg. Thus, the interval between the two doses of neostigmine, when two doses were given, was 5 min. Monitoring was continued until the ratio A ! /A was at least 75%. (The procedure was identical to that used by Hunter, Jones and Utting (1982b) .) Return of A'/A to 75% implies adequate clinical recovery (Ali, Utting and Gray, 1971a) .
Monitoring
Neuromuscular function was monitored using the train-of-four technique (Ali, Utting and Gray, 1971a, b; Ali and Savarese, 1976) ; the details of its application have been given (Hunter, Jones and Utting, 1982a) . The stimulator was a Grass type S48 and the force-displacement transducer a Grass type FT03C. (For simplicity, and because the first response to the train-of-f our only was easily measurable when incremental doses of drug were given, the ratio of the height of the first twitch to control (A 1 /A) is used throughout this paper.) Cardiovascular function was monitored simply. Heart rate and arterial pressure, determined by palpation, were recorded at 1-min intervals during induction until the response to the train-of-four stimuli had disappeared or reached its minimum. Later both variables were recorded at intervals of 5 min.
RESULTS
Blocking action of the initial dose
The percentage of patients in each group in which the mechanical response to the train-of-four stimuli was completely ablated initially is presented in table III. Thus, for example, in all normal patients who received atracurium the twitch responses disappeared completely after the initial dose of the drug had been given, but this happened in only 30% of the anephric patients who received tubocurarine Apart from two anephric patients, both of whom received vecuronium, atracurium and vecuronium caused either complete ablation of the twitch responses or at least a decrease in the percentage ratio A 1 /A to 10% or less (the other three twitch responses disappeared completely in both normal and anephric patients). In the two exceptional anephric patients who received vecuronium, the maximum percentage depression of A 1 /A was to 12 and 13%. Subsequently, both these patients showed evidence of being resistant to vecuronium and are commented on separately later.
The results obtained from the initial dose of tubocurarine were different. Thus, complete ablation of the response to the stimuli occurred in only 62% of the normal patients and in only about 30% of both groups of anephric patients who received the drug. Moreover, the minimum value of the ratio A 1 /A after tubocurarine had been given in both normal and anephric patients was often greater than 10%: for example, in one of the normal patients receiving tubocurarine 0.6mgkg~' the ratio A'/A never decreased below 18%; in one of the anephric patients receiving the smaller dose of tubocurarine it never decreased to less than 28%; and in one of the anephric patients receiving the larger dose it never decreased below 18%.
Speed of onset of initial dou
The times from administration of the first dose of neuromuscular blocking drug to the first observable depression of the response to the train-of-four stimuli in seconds, and the time to mmHmnl depression or to disappearance of the twitch, also in seconds, for both the normal and anephric patients given each of the drugs studied, are detailed in table IV; statistically significant differences between these two variables for the drugs are presented using the times for atracurium in normal patients as the index of comparison.
In normal patients the onset of action (first depression) of atracurium, and the time to maximum depression or complete ablation of the responses, were more rapid than with vecuronium (P< 0.05). In the normal group of patients who received tubocurarine 0.6mgkg"', the time to first depression of the twitch was similar to that of atracurium and vecuronium, but the time to mmrimni depression or disappearance was longer than with atracurium (P<0.05) but not significantly different from that of vecuronium.
In the anephric patients the mean time to both first depression and to maximum depression or ablation was longer over-all than it was in normal patients given the same drug. However, only with atracurium did this difference achieve significance.
Duration of action of initial dose
Details of the recovery times from the initial dose of blocking drug are given in table V. This shows the time to re-appearance of the twitch response after the initial dose had been given in those patients in whom the twitch disappeared completely with both atracurium and vecuronium, together with the In normal patients the most obvious finding was that vecuronium was shorter acting than atracurium and that the differences between the two were significant when considering both the time to reappearance of the twitch and to 10% recovery (P<0.05 in both cases). The time to 10% recovery of the twitch height appeared to be somewhat longer with tubocurarine than it did with the other two drugs, but this difference only achieved significance when anephric patients receiving tubocurarine 0.6 mg kg" 1 were compared with vecuronium in normal patients (P<0.05).
In anephric patients the duration of action of atracurium was the same as in normal patients. The duration of action of the initial dose of vecuronium appeared to be slightly prolonged in this group, but this difference did not reach statistical significance. In the group receiving tubocurarine in which direct comparison with normal patients was possible (those receiving 0.6 mg kg" 1 ) there was little difference between normal and anephric patients in the mean time to 10% recovery and, indeed, little difference between anephric patients receiving 0.5mgkg"' or 0.6mgkg~'. Tubocurarine appeared to last longer in anephric patients than did atracurium and vecuronium, but the differences did not achieve statistical significance.
The salient finding with tubocurarine in anephric patients was that it was unpredictable. For example, one of the patients receiving the smaller dose of the drug showed depression of the height of the initial TABLE VI. Conditions for endotracheal intubation in the different groups of patients 901 after the initial dose of blocking drug had been given. Conditions wen said to be "good" if the cords wen abducted and then was no cough when the tube waspasstd, "adequate" if then was slight cough only, and "poor" if then was any reaction other than slight cough twitch to only 28% of control whilst another patient receiving the same dose showed complete ablation of the response and 10% recovery of the initial twitch height was not achieved for about 3 h.
Conditions
Conditions for endotracheal intubation
The conditions for endotracheal intubation 90 s after the initial dose of neuromuscular blocker are shown in table VI. Atracurium appeared to provide better conditions than the other two drugs, but the differences were marginal. As endotracheal intubation is a procedure which depends on the degree of central depression as well as neuromuscular blockade, no further analysis was attempted in these small groups of patients. However, it will be realized that the time to mnTimnm depression of the train-of-f our was earlier in the group of normal patients who received atracurium (table IV) .
Duration of action of incremental doses
Details of the duration of action of incremental doses of both atracurium and veoironium are given in table VII. Increments were given when the ratio A'/A was 20% (in practice this was not exactly so, but the differences were small, amounting to a maximum of only 2-3%). Results from the two anephric patients said to be resistant to vecuronium have been excluded from this table and their results recorded separately (below).
There was no evidence of a progressive increase in the duration of action of increments of atracurium or vecuronium in either normal or anephric patients. In normal patients the first increment of vecuronium was given at an earlier time than the first increment of atracurium and this difference was significant (P<0.01); the same applied to the second increment, but here the degree of significance was less (P < 0.05); after the second increment there was no statistically significant difference in the times at which the incremental doses were given.
In anephric patients there was no significant difference in the times at which increments of either drug were given, compared with the times for the same drug given to normal patients. There was no evidence of an increase in the time between increments.
The largest dose of atracurium administered to normal patients was 1.7 mg kg" 1 and of vecuronium, 0.34 mgkg" 1 ; the largest dose of atracurium administered to anephric patients was 2.3 mgkg" 1 and of vecuronium 0.34mgkg"' (but see "resistant" patients).
"Resistant" patients
Two of the anephric patients given vecuronium were resistant to the agent and the study had to be abandoned: details are given in table Vlll. One of the patients was given 14 increments over 216 min at intervals of 11-27 min but the ratio A 1 /A did not decrease below 64% with any increment. The second patient was given 13 increments at intervals of 8-13 min and here the ratio A'/A was never below 23%. The total doses used were thus 0.66 and 0.62 mgkg" 1 , respectively. There did not seem to be any abnormality in the batches of drugs used; other ampoules from the same boxes were found to have the anticipated pharmacological effect. Both these patients were young (ages 14 and 16yr respectively) and small (34 kg and 39 kg, respectively). Both were presented for graft nephrectomy and were considered to be relatively unfit (ASA grade 4).
Reversal of neuromuscular block
The number of patients receiving two doses of neostigmine 2.5 mg is shown in be noted that the results would be expected to depend on the ratio A'/A present before the first dose was given, and this varied according to the clinical conditions at the time but was always at least 20%. Thus, it is not possible to make an adequate comparison between the various groups. At the end of anaesthesia, clinical reversal of neuromuscular blockade was considered to be adequate in every patient. However, when tubocurarine had been used in anephric patients there was evidence of diplopia or blurring of vision after operation in 16% of patients receiving the smaller dose, and in 30% of those receiving the larger. In some patients these effects were still present the day after surgery. This phenomenon was not seen in the group of normal patients given tubocurarine, nor in any patients who received atracurium or vecuronium.
Cardiovascular effects
The mean heart rates and systolic arterial pressures recorded immediately before and 1 min after the initial dose of neuromuscular blocker had been given are presented in table X, the maximum changes in both being noted about 1 min after the administration of the drug.
Changes in heart rate were small and there were none which could be considered clinically significant. There were, however, more obvious changes in systolic arterial pressure. Among normal patients there was a decrease in systolic arterial pressure when tubocurarine 0.6mgkg~1 was given (P<0.01); there was also evidence of a decrease when atracurium was given but this was not statistically significant. No change was found in patients given vecuronium. In the anephric groups the only group not to show a significant decrease in arterial pressure was the group receiving vecuronium; in the group receiving atracurium and in both of the groups receiving tubocurarine there were decreases which were significant (P<0.05 in each case). 
DISCUSSION
The most important finding recorded is that vecuronium, like atracurium, can be used in anephric patients in large doses without there being evidence of residual curarization. In those anephric patients who reacted normally to the drug, a dose of up to 0.34mgkg" 1 was given. This is over four times the dose generally said to be required for endotracheal intubation (0.08 mg kg"
1
) and yet recovery following neostigmine was prompt and adequate. In those anephric patients who were designated resistant, the total dose given was nearly twice as great as the mnyiTrmm dose given to the others and here, although the drug was relatively ineffective, there was no evidence of residual curarization.
The finding that two of the anephric patients were resistant to vecuronium is impossible to explain in the light of present knowledge and it is, of course, possible that normal patients may be found who behave the same way. There is some indication in this study that renal patients may, surprisingly, appear to be slightly resistant to the initial dose of a non-depolarizing drug. Thus, the proportion of patients snowing complete ablation of the response to the train-of-four stimuli was less in the anephric patients than in normal patients. It may be that the anephric patients had a higher initial volume of distribution, although this is not substantiated by phannacokinetic studies (Fahey et al., 1981a) in which results were obtained in anephric patients similar to those in patients with normal renal function. However, the degree of resistance to vecuronium shown by the two patients is too great to admit to this explanation.
Both the resistant patients were young (14 and 16yr), small (34 and 39 kg) and poorly developed. Fisher and Miller (1983) found that paediatric patients showed some degree of resistance, but this was less than that encountered here. However, a considerably greater degree of resistance has been found in some paediatric patients with normal renal function (Nightingale, personal communication).
The present work invites a direct comparison between atracurium and vecuronium. It is, however, difficult to compare the potencies of the inii-inl doses used. It is a crucial limitation of using the mechanical responses to nerve stimulation to assess neuromuscular blockade, that adequate quantification is impossible if the response disappears completely. Despite this, the results suggest that vecuronium O.lmgkg" 1 is slightly less effective than atracurium O.Smgkg" 1 for, although atr^-urium abolished the twitch response completely in all the normal patients and in 93% of the anephric patients, vecuronium abolished the twitch in only 2P% of normal patients and in 71 % of the anephric patients.
Previous work with cumulative dose-response curves in normal patients would suggest that the two doses should be equipment (Gramstadt and Lilleaasen, 1982) ; indeed, Foldes and colleagues (1983) found vecuronium to be slightly more potent.
In normal patients, although not in the anephric patients, the speed of onset of blockade after the initial dose was faster with atracurium than with vecuronium. This difference, however, is more of academic than of clinical importance since it has been found, using an identical technique of anaesthesia and monitoring, that the onset of action of suxamethonium is nearly twice as fast as that of atracurium (Hunter, Jones and Utting, 1982a) . Suxamethonium still remains, therefore, the most suitable drug when, for example, there is danger of inhalation of gastric contents.
In normal patients the initial dose of atracurium lasted longer than the initial dose of vecuronium and the difference was clinically (as well as statistically) significant: vecuronium was a shorter acting drug than atracurium. This finding is in general agreement with that of Foldes and colleagues (1983) who compared the times to 25% recovery of twitch height ("clinical duration") but found the difference between the two agents to be slightly less than was found here. This difference was not evident in the results from the anephric patients: in this group the initial dose of vecuronium appeared to last slightly longer than it did in normal patients, but with atracurium the duration of action was the same in the two groups.
Ah ' and colleagues (1983) found that spontaneous recovery (from 5 to 25% of the original twitch height of the train-of-four) was slower with a fifth incremental dose than with a first for both atracurium and vecuronium, and that the difference was significant, being somewhat more marked for vecuronium than for atracurium. This was thought to be indicative of cumulation. However, the differences observed were quite small. Other workers (Buzello and Noldge, 1982) failed to find evidence of this effect with vecuronium even when the total dose given was 0.5 mg kg"'.
It is impossible with the present data to present such precise comparisons. The important fact would seem to be that up to six increments of atracurium and five of vecuronium were given to normal patients (total doses of 1.7 ing kg" 1 and 0.3 mg kg"', respectively) and up to nine increments of atracurium and 14 of vecuronium to anephric patients (total dose of 2.3 mgkg" 1 and 0.67 mgkg" 1 , respectively) and yet reversal of neuromuscular blockade with neostigmine was always prompt and effective. This would argue that, within this dose range, there was no cumulation which was clinically important with either drug in either normal or anephric patients. Vecuronium caused no detectable change in heart rate or arterial pressure in either normal or anephric patients. Atracurium, however, caused a small decrease in arterial pressure in both groups and this reached significance in the anephric patients. If vecuronium was less predictable as a neuromuscular blocking agent in renal failure than atracurium, it seemed to have less effect on the cardiovascular system than the other drug.
It is interesting to note that complete ablation of the twitch response was not obtained in 38% of patients who received tubocurarine 0.6mgkg" 1 which, in the clinical context, must be considered to be a very large dose. This finding can be contrasted to that of Katz (1967) who found that tubocurarine 0.1 mgkg" 1 sometimes caused complete ablation of the twitch and sometimes had no apparent effect at all. It is surprising that such a variable action should be clinically satisfactory. Vecuronium 0.1 mgkg" 1 also did not cause complete ablation of the twitch in 10% of patients, although here the degree of residual blockade was less than with the older agent.
The explanation that tubocurarine, like the other older non-depolarizing agents such as gallamine, is unsatisfactory in patients with no renal function has been afforded by pharmacokinetic data and this has been well summarized by Buzello and Agoston (1978) . Although no pharmacokinetic studies are reported here, the mechanical twitch responses would augment the view that the drug is unsatisfactory in these circumstances because of the large range of results obtained.
The initial doses of tubocurarine (0.5 or 0.6mgkg" 1 ), which would be considered large by normal standards, did not give satisfactory relaxation in some patients (although this would probably have been achieved if volatile adjuvants had been given). At the other extreme, however, even the smaller dose gave up to 3 h of complete ablation of the twitch in one patient; in other words the effects of tubocurarine were very variable. In these circumstances a clinical anaesthetist may give an excessive amount of the drug to anephric patients and find that effective recovery did not take place, perhaps, for several hours. An additional indication of the long action of tubocurarine is given by the persis-tence of blurring of vision or of diplopia for many hours after surgery. As this occurred only in anephric patients it seems reasonable to suppose that this was a result of persistence of the drug. 1 ; dosis crecientcs de 0,04mgkg"') a21 parientes normaleay a 21 pacientes anefricos. No hubo diferencias marcadas entre ambos grupos en el efecto o en la duracion de la acdon de cualquiera de las dosis, inin'alfs o incrementadas, salvo en dos pacientes anefricos que demostraron Una resistencia al agente. La inversi6n mediante neoestigmina fue satisfactoria. En los pacientes normales, la dosis inicial de vecuronio era mas lenta en surtir efecto que la dosis de 0,5 ing kg" 1 (26 pacientes): las dos primeras dosis incrementadas de vecuronio fueron administradas mucho antes que los incremental correspondientes del atracurio (0^ mgkg" 1 ), pero la duracion de accion global de los incremented no difirio sensiblemente. Sin embargo, en los pacientes anefricos, salvo en los que demostraron resistencia, el comportamiento del vecuronio era similar al del atracurio (26 pacientes). Una comparacion con una dosis inicial de 0,5mgkg"' de tubocurarina administrada a 20 pacientes anefricos y de 0,6mgkg" 1 administrada a 21 pacientes normales y a 20 pacientes anefricos demostro que la tubocurarina tiene una acci6n mas larga y crwiffH^rBhTfmfntf imprevisible. Esto se observ<3 esprrifllmmte en el grupo anefneo en el cual su accion a veces persistio despues de la administracion de neoestigmina.
UNE COMPARAISON ENTRE VECURONIUM, ATRACURIUM ET TUBOCURARINE CHEZ DES PATIENTS NORMAUX ET CHEZ DES PATIENTS ANEPHRIQUES
